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number of harmful agents, such as proteolytic enzymes
and oxygen-derived free radicals, which can damage sur-
rounding cells and extracellular structures. In addition to
the neutrophil-induced direct injury of parenchymal
cells, chemotactic stimulation enhances PMN adhesion
to endothelial cells and homotypic aggregation, thus
leading to plugging of microvessels, reduction in coro-
nary blood flow, and further extension of tissue injury.
Substantial evidence has been derived from experimental
studies to support an important role of neutrophils in
injury after prolonged ischemia/reperfusion. Inter-
ventions aimed at systemic depletion of circulating neu-
trophils such as leukocyte filters, antineutrophil antibod-
ies, or hydroxy urea resulted in significant reduction of
myocardial infarct size in an animal model.1-3 Similar
results were obtained in experiments investigating anti-
complement or antiadhesion approaches.4-6
Activated polymorphonuclear neutrophils (PMNs) areknown to play a pivotal role in the secondary inflam-
matory response to myocardial ischemia/reperfusion
injury. When stimulated, neutrophils are able to release a
Objectives: This study was designed (1) to evaluate the influence of plasma
obtained from patients undergoing coronary artery bypass grafting on L-
selectin, CD11b, and CD18 expression on human neutrophils and (2) to
determine the influence of the use of crystalloid or blood cardioplegia dur-
ing bypass grafting on plasma-mediated expression of adhesion molecules
on polymorphonuclear neutrophils. 
Patients and methods: Patients undergoing coronary artery bypass grafting
were divided into 2 groups to receive crystalloid or blood cardioplegic solu-
tions. Peripheral vein, radial artery, and coronary sinus blood samples were
drawn at aortic crossclamping, aortic crossclamp release, and 30 minutes
after reperfusion. Human neutrophils were incubated with patients’ plasma,
and the expression of CD11b, CD18, and L-selectin was determined with
flow cytometry. 
Results: In patients receiving crystalloid cardioplegic solutions, plasma sam-
ples collected from the coronary sinus at aortic clamp release and 30 minutes
thereafter induced significantly higher expression of neutrophil CD11b and
CD18 than plasma samples obtained from a peripheral vein or artery at the
same time points. The expression of L-selectin on polymorphonuclear neu-
trophils was significantly reduced with plasma obtained 30 minutes after
reperfusion as compared with samples collected at aortic crossclamp release.
In the group receiving blood cardioplegia, no significant differences in
CD11b, CD18, or L-selectin expression were found. 
Conclusions: (1) Ischemia/reperfusion after coronary artery bypass grafting
is associated with the release of factors capable of neutrophil activation from
myocardium into the circulating blood. (2) The release of soluble stimuli for
neutrophils during bypass grafting may be modified by the cardioplegic
solution. (J Thorac Cardiovasc Surg 2000;119:1270-7)
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The noxious effects of neutrophils are thought to be
specifically dependent on certain adhesion glycopro-
teins that are expressed on the surface of leukocytes,
endothelial cells, and myocytes. L-selectin, a member
of the selectin family, which is constitutively expressed
on lymphocytes and neutrophils, is important for the
first contact between PMNs and endothelial cells. Its
activity is responsible for neutrophil margination and
allows other adhesive mechanisms to operate.
Activation of leukocytes results in rapid disappearance
of the antigen from the cell membrane. Shed material—
soluble form of L-selectin—can be found in normal
serum. CD11b/CD18, or leukocyte adhesion receptor
Mo1, belongs to the integrin family. It is a heterodimer
composed of a β-chain, known as CD18, coupled to an
α-chain (CD11b). This antigen is present in low con-
centration on the surface of unstimulated neutrophils,
monocytes, and macrophages. On chemotactic stimula-
tion, it becomes rapidly (within minutes) up-regulated.
CD11b/CD18 seems to play a pivotal role in the process
of neutrophil-mediated ischemia/reperfusion injury: It
is responsible for PMN adherence to the endothelium
and subsequent extravasation and accumulation at sites
of inflammation; it is involved in neutrophil aggrega-
tion; and it modulates parenchymal cell toxicity due to
neutrophil-derived free radical activity.7,8
Neutrophil activation on ischemia/reperfusion may
result from a direct contact with endothelial adhesion
molecules expressed in the ischemic heart, or it can be
mediated by certain stimuli released from myocardium
to the circulating blood. In a previous study, plasma
obtained from peripheral blood of patients with acute
myocardial infarction had a potential to induce integrin
expression and reactive oxygen species production by
control PMNs, thus confirming the latter possibility.9
The aim of this study was to investigate whether stim-
uli capable of neutrophil activation are released from
ischemic and reperfused myocardium during coronary
artery bypass grafting (CABG). We evaluated the
expression of CD18, CD11b, and L-selectin on human
neutrophils incubated with plasma obtained from
patients undergoing routine CABG. In addition, we
compared plasma-mediated stimulation of PMN adhe-
sion molecule expression in patients receiving crystal-
loid and blood cardioplegic solutions during the CABG
procedure.
Patients and methods
Patients studied. The study group consisted of 50 patients
with coronary artery disease from a total of 950 patients
qualified for CABG during a 1-year period on the basis of
the routinely used clinical and angiographic criteria. So that
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we could avoid the possible effect of the maneuvers on the
results, all patients included in the study group were operat-
ed on by the same team (n = 83). The exclusion criteria were
a history of heart surgery, recent myocardial infarction (<3
months), diabetes mellitus, renal failure, the use of inotropic
support or intra-aortic balloon pumping during the opera-
tion, and the existence of an inflammatory disease, factors
which are known to affect PMN function. Patients undergo-
ing CABG as a minimally invasive procedure and those
being operated on without aortic crossclamping were also
excluded. Thus, of the 83 patients, 33 patients were exclud-
ed. Ejection fraction estimated by echocardiography ranged
from 28% to 68% (mean 68%). The bypass circuit period
ranged from 51 to 182 minutes (mean 86 minutes), and the
aortic clamping time was 17 to 64 minutes. During car-
diopulmonary bypass (CPB), the hematocrit value was kept
minimally at 22% to 25%, potassium at 5.5 to 6.0 mmol/L,
and diuresis was maintained at 100 to 150 mL/h, with the use
of furosemide as necessary.
The operation was performed with CPB at moderate
hypothermia (30˚-32˚C). Patients were randomly assigned to
1 of 2 groups. In group A, myocardial preservation was
achieved by antegrade infusion of cold crystalloid St
Thomas’ Hospital cardioplegic solution. In group B, ante-
grade blood cardioplegia according to Buckberg (blood and
crystalloid solution in a 4:1 ratio) was used. After grafting,
patients were rewarmed to 36˚C and separated from CPB by
the gradual reduction of venous return to the bypass circuit.
Finally, 50 patients (8 women and 42 men; 34-73 years,
mean age 53 years) were enrolled in the study (25 in each
group). No patient was excluded after randomization. No sta-
tistically significant differences in mean age, sex, left ven-
tricular ejection fraction, CPB time, and myocardial ischemia
time were found between the 2 study groups. 
Informed consent to participate in the study, which was
accepted by the local ethics committee, was obtained from
each subject.
Patients’ plasma samples. Peripheral venous blood sam-
ples were drawn into tubes containing heparin (5 IU/mL)
before the installation of CPB. Other samples were collected
from the basilic vein, the radial artery, and the coronary sinus
directly before myocardial ischemia (aortic crossclamping),
at the beginning of reperfusion (aortic clamp release), and 30
minutes after reperfusion. The samples were immediately
centrifuged and the plasma was deeply frozen (70˚C) until
analysis to enable simultaneous examination of all plasma
samples.
Neutrophil preparation and flow cytometry. Neutrophils
were isolated from peripheral blood samples obtained from
healthy volunteers. PMNs were isolated by a single-step cen-
trifugation procedure on Gradisol gradient (Polfa, Kutno),
which is a modification of the method described by Böyum.10
After centrifugation, neutrophils were washed twice and sus-
pended in 10 mL of saline solution. Red blood cells were
lysed with hemolytic buffer (0.828 g NH4Cl and 0.1 g
KHCO3 dissolved in 100 mL of distilled water with 20 µL of
1N NaOH). The neutrophils were resuspended in Hanks solu-
tion (Sigma Chemical Co, St Louis, Mo). PMNs were incu-
bated with patients’ plasma samples or St Thomas’ Hospital
cardioplegic solution for in vitro testing (15 minutes at 37˚C),
and the expression of CD18, CD11b, and L-selectin was
determined by direct 2-color immunofluorescence staining of
blood leukocytes and flow cytometry. Aliquots of neutrophil
suspension were incubated for 30 minutes with fluorescein
isothiocyanate- or phycoerythrin-conjugate murine mono-
clonal antibodies to human CD18, CD11b, or L-selectin
(Becton Dickinson, Oxford, United Kingdom). The cells
were washed 3 times with phosphate-buffered saline solution,
resuspended in Isoton solution (Becton Dickinson, Franklin
Lakes, NJ), and flow cytometry analysis was performed
immediately. Flow cytometry was performed with a Becton
Dickinson FACScan instrument equipped with an argon laser
(488 nm) and 3 bandpass filters. Ten thousand events were
acquired from each sample. A gate was drawn around the
granulocyte population identified by the characteristic for-
ward and side scatter profile. The neutrophils that expressed
levels of fluorescence for an individual adhesion molecule
that exceeded nonspecific background fluorescence were
considered to be positively labeled for that molecule. The
level of surface expression for each adhesion molecule was
assessed as the mean fluorescence intensity of staining for
that molecule.
Statistical analysis. Since the data were not normally dis-
tributed, as assessed by the Kolgomorov-Smirnov test, statis-
tical analysis was performed by the nonparametric repeated-
measures analysis of variance within groups and with the
Mann-Whitney test for comparisons between groups. Data
are shown as means ± SD.
Results
The in vitro influence of St Thomas’ Hospital car-
dioplegic solution on β-integrin expression.  In-
cubation of neutrophils with St Thomas’ Hospital car-
dioplegic solution in in vitro conditions resulted in a
significant decrease in the expression of CD11b and
CD18 on these cells (Fig 1).
Plasma-mediated changes in the expression of
CD11b. The expression of CD11b by PMNs (Fig 2)
stimulated with plasma obtained before the installation
of CPB did not differ between the 2 study groups. In
patients receiving crystalloid cardioplegic solution, the
CD11b expression of neutrophils induced by plasma
obtained from the coronary sinus at aortic crossclamp
release was significantly higher (P < .05) than that
mediated by plasma obtained from the radial artery and
basilic vein at the same time (371.1 ± 5.5 vs 318.4 ±
79.5 and 333.0 ± 170.5 mean fluorescence, respective-
ly). Expression of CD11b by neutrophils incubated
with plasma collected from the coronary sinus at 30
minutes of reperfusion was significantly higher than at
aortic crossclamping and aortic crossclamp release
(437.1 ± 155.5 vs 293.3 ± 76 and 371.1 ± 95.5 mean
fluorescence, respectively). However, in patients
receiving blood cardioplegia, no significant increase in
the PMN CD11b expression was observed when cells
were incubated with plasma taken at the beginning of
reperfusion. Thirty minutes thereafter, plasma-mediat-
ed stimulation in the coronary sinus was significantly
lower in these patients, as compared with subjects
receiving crystalloid cardioplegia (374.5 ± 113 vs
437.1 ± 155.5, P < .05). 
Plasma-mediated changes in the expression of
CD18. The patterns of changes in CD18 expression
(Fig 3) in the group receiving crystalloid cardioplegic
solution paralleled those described for CD11b. CD18
expression by PMNs incubated with plasma collected
from the coronary sinus at aortic crossclamp release
was significantly higher than that induced by plasma
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Fig 1.  The in vitro effect of increasing concentrations of St
Thomas’ Hospital cardioplegic solution on CD11b (A) and
CD18 (B) on neutrophils.
A
B
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obtained from the radial artery at the same time (51.4
± 8 vs 45.3 ± 8 mean fluorescence, P < .05).
Expression of CD18 induced by plasma collected from
the coronary sinus 30 minutes after reperfusion was
significantly higher than CD18 expressions mediated
by plasma samples obtained from the radial artery at
the same time and from the coronary sinus at aortic
clamping and aortic clamp release (56.9 ± 9 vs 49.6 ±
11, 37.1 ± 7.5 and 51.4 ± 8 mean fluorescence, respec-
tively; P < .05). In 25 patients receiving blood cardio-
plegic solution, no significant differences were
observed when PMNs were incubated with plasma
samples obtained from the coronary sinus, peripheral
vein, or peripheral artery at aortic clamping, at aortic
clamp release, or 30 minutes after reperfusion.
Plasma-mediated changes in the expression of L-
selectin. In patients receiving crystalloid cardioplegic
solution, L-selectin expression by PMNs (Fig 4) incu-
bated with plasma drawn from the coronary sinus 30
minutes after reperfusion was significantly lower than
at aortic clamp release (11.8 ± 7.5 vs 17.3 ± 8 mean flu-
orescence, P < .05). In the blood cardioplegia group, no
significant differences in mean fluorescence values for
L-selectin were found.
Discussion
Much attention has recently been focused on the role
of PMNs in complications after ischemia/reperfusion
during CABG. Activation of neutrophils during cardiac
surgery with CPB is a well-known phenomenon.
Activated leukocytes seem to play a pivotal role in
inflammatory reactions initiated by CPB11 that may
lead to organ dysfunction.12 Moreover, oxygen-derived
free radicals released by activated PMNs may con-
tribute to myocardial stunning often observed after car-
diac operations.13 The clinical relevance of leukocyte
activation during CABG has recently been demonstrat-
ed in a few studies investigating the use of leukocyte-
depleted cardioplegic solution or antiadhesion strate-
gies. It has been shown that leukocyte depletion as an
Fig 2.  The effect of plasma obtained during CABG from patients receiving crystalloid (A) or blood (B) cardio-
plegic solutions on CD11b expression of neutrophils. Plasma samples were taken from peripheral vein, peripheral
artery, and coronary sinus before myocardial ischemia (at aortic crossclamping), at the beginning of reperfusion (at
aortic clamp release), and 30 minutes after reperfusion. Mean values ± SD. *P < .05 versus peripheral vein and
artery. **P < .05 versus before ischemia and at the beginning of reperfusion. 
A
B
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adjunct to terminal blood cardioplegia was associated
with better clinical outcome in patients with left ven-
tricular hypertrophy.14 Similarly, the inhibition of
leukocyte-endothelial interaction by monoclonal anti-
bodies against leukocyte adhesion molecules seems to
have a beneficial effect on myocardial function after
heart surgery both in animals15-17 and in human
beings.18
As intercellular adhesion is a critical step in the
sequence of events leading to granulocyte-dependent
tissue injury, the changes in neutrophil expression of
adhesion molecules during cardiac operations have
been extensively studied. In the majority of studies the
β-integrin expression was found to be up-regulated
during CPB. Increased expression of CD11b/CD18 on
neutrophils was observed in isolated CPB circuits19,20
and in animal models,21,22 as well as in human
beings.23-25 However, in these studies the mechanisms
leading to PMN activation remained unclear. The
enhanced β-integrin expression could be related not
only to inflammatory stimuli released in ischemic tis-
sues but also to interactions with endothelial adhesion
molecules or to direct contact of the blood with syn-
thetic surfaces of the CPB circuit. The present study
has clearly demonstrated that ischemia and reperfusion
during CABG is associated with release of stimuli
enhancing integrin expression by PMNs. In neutrophils
obtained from healthy volunteers and incubated with
plasma collected from the coronary sinus at the begin-
ning of reperfusion (aortic clamp release) and at 30
minutes of reperfusion, expression of both CD11b and
CD18 was significantly higher than that observed at the
time of aortic crossclamping. Moreover, CD11b and
CD18 expression was enhanced exclusively by the
plasma from coronary sinus. As St Thomas’ Hospital
solution in vitro inhibited both CD11b and CD18
Fig 3.  The effect of plasma obtained during CABG from patients receiving crystalloid (A) or blood (B) car-
dioplegic solutions on CD18 expression of neutrophils. Plasma samples were taken from peripheral vein,
peripheral artery, and coronary sinus before myocardial ischemia (at aortic crossclamping), at the beginning of
reperfusion (at aortic clamp release), and 30 minutes after reperfusion. Mean values ± SD. *P < .05 versus
peripheral artery. **P < .05 versus before ischemia and at the beginning of reperfusion.
A
B
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expression by PMNs, the stimulatory effect of the plas-
ma obtained from the coronary sinus probably resulted
from local ischemia and reperfusion. Furthermore, the
difference between arterial and coronary sinus samples
suggests that the effect was independent of the possible
influence of extracorporeal circuit. The CD11b expres-
sion in the presence of plasma collected from a periph-
eral vein or artery at any time point was even somewhat
lower than the value obtained before the procedure,
which was probably an effect of the dilution of plasma
in the CPB circuit. The observed plasma-mediated up-
regulation of surface β-integrin expression on neu-
trophils corresponds with previous findings suggesting
that factors capable of stimulating of PMN adhesion
are released from the myocardium after ischemia and
reperfusion during CABG.26 In contrast to changes in
the β-integrin expression, in vitro activation of neu-
trophils results in rapid decrease in surface expression
of L-selectin, probably due to shedding.27 This pattern
was found in our study, in which L-selectin expression
on PMNs incubated with plasma collected from the
coronary sinus of patients receiving crystalloid cardio-
plegic solution at 30 minutes of reperfusion was signif-
icantly lower than at aortic clamp release.
The interesting question arises of what could be the
soluble stimuli responsible for neutrophil activation
during heart surgery. Of the mediators that have been
implicated in reperfusion-induced leukocyte activation,
platelet-activating factor, leukotriene B4, complement
fragments, tumor necrosis factor, and endothelins have
received the greatest attention.28 A previous study
demonstrated that endothelin-1 was involved in stimu-
lation of neutrophil adherence during CABG.26 It was
also reported that release of platelet-activating factor
resulted in neutrophil activation after ischemia and
reperfusion during acute myocardial infarction and
coronary angioplasty.9,29 Nevertheless, it is possible
that during ischemia and reperfusion numerous media-
Fig 4.  The effect of plasma obtained during CABG from patients receiving crystalloid (A) or blood (B) cardio-
plegic solution on L-selectin expression of neutrophils. Plasma samples were taken from peripheral vein, periph-
eral artery, and coronary sinus before myocardial ischemia (at aortic crossclamping), at the beginning of reperfu-
sion (at aortic clamp release), and 30 minutes after reperfusion. Mean values ± SD. *P < .05 versus at the beginning
of reperfusion.
A
B
tors are released and their orchestrated action is
involved in systemic PMN activation. Experimental
design used in the present study enabled us to evaluate
the total effect of those mediators that were of clinical
relevance.
No significant changes in CD11b, CD18, and L-
selectin expression were observed in the group receiv-
ing blood cardioplegic solution. At this stage of inves-
tigation, the exact mechanism responsible for the
differences between groups receiving crystalloid and
blood cardioplegic solutions is unclear. It was previ-
ously shown that the use of blood cardioplegia may
reduce the release of proinflammatory cytokines in
patients undergoing cardiac surgery.30 The possible
influence of other factors, including changes in osmo-
larity, cannot be ruled out. The difference in β-integrins
and L-selectin surface expression in both study groups
indicates that cardioplegia itself may influence the
release of neutrophil-oriented stimuli from ischemic
myocardium and thus modify neutrophil activation dur-
ing CABG. This finding may be of clinical relevance
and requires further investigation.
Conclusions
1. Ischemia and reperfusion after CABG results in
the release of factors capable of PMN stimulation from
the myocardium to the circulating blood.
2. The release of soluble stimuli for PMNs during
CABG may be modified by the cardioplegic solution.
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